Overview

Foley's Catheter Balloon Plus Tranexamic Acid During Cesarean Delivery for Placenta Previa

Status:
Unknown status
Trial end date:
2021-02-01
Target enrollment:
0
Participant gender:
Female
Summary
Placenta previa (PP) is an obstetric condition that is closely linked with massive obstetric hemorrhage with a varied incidence about once in every 150-250 live births. Insertion of intrauterine balloon tamponade has been suggested in the management of massive postpartum hemorrhage (PPH). The Bakri balloon has a sausage-like spindle shape and a drainage lumen and is made of silicon. It has been used in cases of uterine atony and placenta previa with a success rate of 90%. However, Bakri balloon is not available in all countries. The aim of this study is to evaluate the efficacy of the use of intrauterine inflated Foley's catheter balloon with or without intravenous tranexamic acid to control PPH during cesarean delivery in cases of placenta previa.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Aswan University Hospital
Treatments:
Tranexamic Acid
Criteria
Inclusion Criteria:

- all pregnant women with a single term fetus scheduled for an elective cesarean section
for complete placenta previa

Exclusion Criteria:

- Patients with a cardiac, hepatic, renal or thromboembolic disease

- patients with the high possibility of the morbid adherent placenta

- known coagulopathy or thromboembolic disease

- those presented with severe antepartum hemorrhage

- hypersensitivity or contraindications of use of tranexamic acid

- patient refuses to consent